Accessibility Statement

We are committed to providing a website that is accessible to the widest possible audience. To do so, we are actively working with consultants to update the website by increasing its accessibility and usability by persons who use assistive technologies such as automated tools, keyboard-only navigation, and screen readers.

We are working to have the website conform to the relevant standards of the Section 508 Web Accessibility Standards developed by the United States Access Board, as well as the World Wide Web Consortium's (W3C) Web Content Accessibility Guidelines 2.1. These standards and guidelines explain how to make web content more accessible for people with disabilities. We believe that conformance with these standards and guidelines will help make the website more user friendly for all people.

Our efforts are ongoing. While we strive to have the website adhere to these guidelines and standards, it is not always possible to do so in all areas of the website. If, at any time, you have specific questions or concerns about the accessibility of any particular webpage, please contact WebsiteAccess@tenethealth.com so that we may be of assistance.

Thank you. We hope you enjoy using our website.

Skip to Main Content

St. Mary’s Medical Center Enrolls First Florida Patient in the Trevo® Retriever Registry

Jan 5, 2015

International study will evaluate clot retrieval technology in acute ischemic stroke patients

West Palm Beach, Fla. (January 5, 2015) – St. Mary’s Medical Center, a member of the Advanced Neuroscience Network (ANN), is participating in a new clinical trial to collect real-world performance data of the Stryker Neurovascular Trevo® Retrieval System. The retriever is a minimally invasive device intended to restore blood flow in the brain by removing blood clots in patients experiencing acute ischemic stroke.

The Trevo® Retriever Registry may enroll a maximum of 300 patients at up to 40 sites worldwide. The registry will assess the revascularization status of patients treated with the Trevo® Retriever at the end of the procedure and measure functional outcomes at 90 days post-procedure using the modified Rankin Scale (mRS).

“Being the first hospital in Florida to enroll a patient in this trial demonstrates our commitment to advancing the treatment of stroke,” said Davide Carbone, CEO of St. Mary’s Medical Center. “We are proud to contribute to the Trevo® Retriever Registry and continue to provide our patients with the latest in medical technology.”

In the United States, there are an estimated 795,000 strokes every year. Stroke is the fourth most common cause of death and the leading cause of adult disability in the United States.

“Every minute counts in terms of stroke treatment,” said Dr. Ali Malek, the study’s principal investigator and medical director of the Stroke Program at St. Mary’s. “As a Neuroscience Center of Excellence, we are dedicated to clinical research and expanding options for acute ischemic stroke patients.”

The Trevo® Retrieval System was granted 510(k) market clearance by the U.S. Food and Drug Administration (FDA) in October 2012.

For more information about the study, please contact the Clinical Research Coordinator, Murline Smith, at murline.smith@tenethealth.com or call her at 561-623-4980, ext. 275.

Find a Doctor

Need a doctor for your care? 

Sign Up for Health Tips

Get our advice and upcoming events about weight, pain, heart and more.